Overview Fundamentals API Earnings EOD API Sample Code Pricing

CITIUS PHARMAC. DL -001 (47N F) stock market data APIs

€0.3024 0(0%) as of October 29, 2024
Price chart is built with Anychart

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for an initial indication in the treatment of cutaneous T-cell lymphoma. Its late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. The company was founded in 2007 and is headquartered in Cranford, New Jersey.

CITIUS PHARMAC. DL -001 Financial Data Overview

0.3024
0.3024
-
0.3024
0.3024
0.2792-0.933
60 739 K
181 M
0
-0.06
1.611
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '47N',
Type: 'Common Stock',
Name: 'CITIUS PHARMAC. DL -001',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'September',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
CUSIP: NULL,
}

CITIUS PHARMAC. DL -001 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -41 067 916
  • Earnings Per Share -0.22
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get CITIUS PHARMAC. DL -001 Earnings via APIs

  • Latest Release 2021-06-30
  • EPS/Forecast -0.06

Get CITIUS PHARMAC. DL -001 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com